Advertisement
Home 2023

Archives

Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer

0

Findings seen in clear cell renal cell carcinoma patients at very high disease risk after nephrectomy from EVEREST trial

Teplizumab Beneficial for Preserving Beta-Cell Function in Pediatric T1D

0

Benefit seen for preservation of β-cell function in children and adolescents with newly diagnosed type 1 diabetes

Erdafitinib Improves Survival in Metastatic Urothelial Cancer With FGFR Mutation

0

Longer median overall survival and progression-free survival seen with erdafitinib versus chemotherapy

Social Stigma Associated With Adult Facial Acne

0

Faces with acne rated as less attractive, trustworthy, confident, successful, dominant, and happy

IDSA: Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection

0

Incidence of acute kidney injury or death did not differ among those receiving cefepime and piperacillin-tazobactam

IDSA: A. Baumannii, C. Auris Common for Recipients of Mechanical Ventilation

0

A. baumannii, CRAB, C. auris colonization more likely among patients in long-term care facilities than acute care hospitals

IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response

0

All participants exceeded twofold increase in spike-specific IgG, with geometric mean fold risk of 19.5 on day 57

IDSA: Maternal RSVpreF Vaccine Would Cut Clinical, Economic Burden

0

Reduction of 24,520 hospitalizations, 45,957 emergency department encounters, 128,745 outpatient clinic visits anticipated with maternal vaccination

ASTRO: Shorter Radiation Feasible for Low-, Intermediate-Risk Prostate Cancer

0

Findings at five years show 96 percent disease control rate

IDSA: Wastewater Surveillance Allows Monitoring of Viral Infections

0

Positive correlation seen for composite influenza A virus signal with weekly confirmed clinical cases